152 related articles for article (PubMed ID: 8003039)
1. Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein.
Wright MC; Paine AJ
Biochem Biophys Res Commun; 1994 Jun; 201(2):973-9. PubMed ID: 8003039
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
[TBL] [Abstract][Full Text] [Related]
3. Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes.
Amacher DE; Schomaker SJ
Toxicol Lett; 1998 Jan; 94(2):115-25. PubMed ID: 9574808
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes.
Mani C; Pearce R; Parkinson A; Kupfer D
Carcinogenesis; 1994 Dec; 15(12):2715-20. PubMed ID: 8001226
[TBL] [Abstract][Full Text] [Related]
5. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers.
Salphati L; Benet LZ
Biochem Pharmacol; 1998 Feb; 55(4):387-95. PubMed ID: 9514072
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes.
Reid MJ; Lamé MW; Morin D; Wilson DW; Segall HJ
J Biochem Mol Toxicol; 1998; 12(3):157-66. PubMed ID: 9522275
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver.
Lake BG; Renwick AB; Cunninghame ME; Price RJ; Surry D; Evans DC
Toxicology; 1998 Nov; 131(1):9-20. PubMed ID: 9881931
[TBL] [Abstract][Full Text] [Related]
8. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats.
Morita K; Maeda Y; Masuda M; Kazusaka A; Imaoka S; Funae Y; Fujita S
Biochem Pharmacol; 1998 May; 55(9):1405-11. PubMed ID: 10076532
[TBL] [Abstract][Full Text] [Related]
9. Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA.
Li D; Moorthy B; Chen S; Randerath K
Carcinogenesis; 1992 Jul; 13(7):1191-8. PubMed ID: 1638686
[TBL] [Abstract][Full Text] [Related]
10. Comparative induction of CYP3A and CYP2B in rat liver by 3-benzoylpyridine and metyrapone.
Murray M; Sefton RM; Martini R; Butler AM
Chem Biol Interact; 1998 Jun; 113(3):161-73. PubMed ID: 9717516
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyic).
Delaporte E; Cribb AE; Renton KW
Drug Metab Dispos; 1993; 21(3):520-3. PubMed ID: 7686458
[TBL] [Abstract][Full Text] [Related]
12. Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins.
Sadrieh N; Thomas PE
Toxicol Appl Pharmacol; 1994 Aug; 127(2):222-32. PubMed ID: 8048065
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of cyclosporine after orthotopic liver transplantation.
Fabre JM; Pedrosa R; Bonardet A; Pichard L; Descomps B; Domergue J; Baumel H; Maurel P
Biochem Pharmacol; 1993 Oct; 46(7):1151-7. PubMed ID: 8216365
[TBL] [Abstract][Full Text] [Related]
14. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
Menicagli S; Lippi A; Criscuoli M; Gervasi PG
Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
[TBL] [Abstract][Full Text] [Related]
15. Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes.
Yamazaki H; Hiroki S; Urano T; Inoue K; Shimada T
Xenobiotica; 1996 Nov; 26(11):1143-53. PubMed ID: 8948090
[TBL] [Abstract][Full Text] [Related]
16. Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.
Cotreau MM; von Moltke LL; Beinfeld MC; Greenblatt DJ
J Pharmacol Toxicol Methods; 2000; 43(1):41-54. PubMed ID: 11091129
[TBL] [Abstract][Full Text] [Related]
17. Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes.
Yamazaki H; Shimada T
Xenobiotica; 1998 Oct; 28(10):995-1004. PubMed ID: 9849646
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
19. Influence of sex and inducer treatment on the high- and low-affinity forms of hepatic microsomal erythromycin N-demethylase in rats.
Chang T; Levine M; Bellward GD
Can J Physiol Pharmacol; 1990 Dec; 68(12):1510-3. PubMed ID: 2085797
[TBL] [Abstract][Full Text] [Related]
20. Studies on the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase.
Arlotto MP; Sonderfan AJ; Klaassen CD; Parkinson A
Biochem Pharmacol; 1987 Nov; 36(22):3859-66. PubMed ID: 3120728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
